Cme Group Operating Income Growth & History (CME)
Cme Group's operating income was $4.23B for fiscal 2025.
View full Cme Group company overviewCme Group annual operating income history
| Fiscal year | Period ended | Operating income | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $4.23B | $298.0M | +7.58% |
| 2024 | 2024-12-31 | $3.93B | $495.8M | +14.43% |
| 2023 | 2023-12-31 | $3.44B | $419.8M | +13.92% |
| 2022 | 2022-12-31 | $3.02B | $370.7M | +14.01% |
| 2021 | 2021-12-31 | $2.65B | $7.8M | +0.30% |
| 2020 | 2020-12-31 | $2.64B | $49.6M | +1.92% |
| 2019 | 2019-12-31 | $2.59B | −$19.8M | −0.76% |
| 2018 | 2018-12-31 | $2.61B | $297.0M | +12.85% |
| 2017 | 2017-12-31 | $2.31B | $110.1M | +5.00% |
| 2016 | 2016-12-31 | $2.20B | $211.8M | +10.65% |
| 2015 | 2015-12-31 | $1.99B | $220.3M | +12.46% |
| 2014 | 2014-12-31 | $1.77B | $131.4M | +8.03% |
| 2013 | 2013-12-31 | $1.64B | −$55.0M | −3.25% |
| 2012 | 2012-12-31 | $1.69B | −$329.1M | −16.28% |
| 2011 | 2011-12-31 | $2.02B | $190.0M | +10.38% |
| 2010 | 2010-12-31 | $1.83B | $242.0M | +15.23% |
| 2009 | 2009-12-31 | $1.59B | $6.9M | +0.44% |
| 2008 | 2008-12-31 | $1.58B | $530.3M | +50.41% |
| 2007 | 2007-12-31 | $1.05B | — | — |
Cme Group quarterly operating income
| Fiscal quarter | Period ended | Operating income | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $1.11B | −$22.2M | −1.97% |
| Q1 2026 | 2026-03-31 | $1.31B | $201.7M | +18.20% |
| Q4 2025 | 2025-12-31 | $1.02B | $72.5M | +7.65% |
| Q3 2025 | 2025-09-30 | $972.6M | −$51.6M | −5.04% |
| Q2 2025 | 2025-06-30 | $1.13B | $128.7M | +12.86% |
| Q1 2025 | 2025-03-31 | $1.11B | $148.4M | +15.46% |
| Q4 2024 | 2024-12-31 | $947.1M | $83.9M | +9.72% |
| Q3 2024 | 2024-09-30 | $1.02B | $204.0M | +24.87% |
| Q2 2024 | 2024-06-30 | $1.00B | $162.0M | +19.32% |
| Q1 2024 | 2024-03-31 | $959.6M | $45.9M | +5.02% |
| Q4 2023 | 2023-12-31 | $863.2M | $194.9M | +29.16% |
| Q3 2023 | 2023-09-30 | $820.2M | $81.4M | +11.02% |
| Q2 2023 | 2023-06-30 | $838.6M | $88.9M | +11.86% |
| Q1 2023 | 2023-03-31 | $913.7M | $54.6M | +6.36% |
| Q4 2022 | 2022-12-31 | $668.3M | $36.6M | +5.79% |
| Q3 2022 | 2022-09-30 | $738.8M | $125.1M | +20.38% |
| Q2 2022 | 2022-06-30 | $749.7M | $75.0M | +11.12% |
| Q1 2022 | 2022-03-31 | $859.1M | $134.0M | +18.48% |
| Q4 2021 | 2021-12-31 | $631.7M | $116.7M | +22.66% |
| Q3 2021 | 2021-09-30 | $613.7M | $88.7M | +16.90% |
| Q2 2021 | 2021-06-30 | $674.7M | $37.2M | +5.84% |
| Q1 2021 | 2021-03-31 | $725.1M | −$234.8M | −24.46% |
| Q4 2020 | 2020-12-31 | $515.0M | −$58.0M | −10.12% |
| Q3 2020 | 2020-09-30 | $525.0M | −$160.2M | −23.38% |
| Q2 2020 | 2020-06-30 | $637.5M | −$61.1M | −8.75% |
| Q1 2020 | 2020-03-31 | $959.9M | $328.9M | +52.12% |
| Q4 2019 | 2019-12-31 | $573.0M | −$76.9M | −11.83% |
| Q3 2019 | 2019-09-30 | $685.2M | $135.3M | +24.60% |
| Q2 2019 | 2019-06-30 | $698.6M | $31.7M | +4.75% |
| Q1 2019 | 2019-03-31 | $631.0M | −$109.9M | −14.83% |
| Q4 2018 | 2018-12-31 | $649.9M | $113.0M | +21.05% |
| Q3 2018 | 2018-09-30 | $549.9M | −$17.7M | −3.12% |
| Q2 2018 | 2018-06-30 | $666.9M | $61.7M | +10.19% |
| Q1 2018 | 2018-03-31 | $740.9M | $140.0M | +23.30% |
| Q4 2017 | 2017-12-31 | $536.9M | −$3.3M | −0.61% |
| Q3 2017 | 2017-09-30 | $567.6M | $42.3M | +8.05% |
| Q2 2017 | 2017-06-30 | $605.2M | $41.9M | +7.44% |
| Q1 2017 | 2017-03-31 | $600.9M | $27.0M | +4.70% |
| Q4 2016 | 2016-12-31 | $540.2M | $70.3M | +14.96% |
| Q3 2016 | 2016-09-30 | $525.3M | $8.9M | +1.72% |
| Q2 2016 | 2016-06-30 | $563.3M | $68.2M | +13.77% |
| Q1 2016 | 2016-03-31 | $573.9M | $66.6M | +13.13% |
| Q4 2015 | 2015-12-31 | $469.9M | −$1.6M | −0.34% |
| Q3 2015 | 2015-09-30 | $516.4M | $86.0M | +19.98% |
| Q2 2015 | 2015-06-30 | $495.1M | $83.1M | +20.17% |
| Q1 2015 | 2015-03-31 | $507.3M | $52.8M | +11.62% |
| Q4 2014 | 2014-12-31 | $471.5M | $148.3M | +45.88% |
| Q3 2014 | 2014-09-30 | $430.4M | $29.9M | +7.47% |
| Q2 2014 | 2014-06-30 | $412.0M | −$95.8M | −18.87% |
| Q1 2014 | 2014-03-31 | $454.5M | $49.0M | +12.08% |
| Q4 2013 | 2013-12-31 | $323.2M | −$52.4M | −13.95% |
| Q3 2013 | 2013-09-30 | $400.5M | $4.5M | +1.14% |
| Q2 2013 | 2013-06-30 | $507.8M | $38.6M | +8.23% |
| Q1 2013 | 2013-03-31 | $405.5M | −$45.7M | −10.13% |
| Q4 2012 | 2012-12-31 | $375.6M | −$14.8M | −3.79% |
| Q3 2012 | 2012-09-30 | $396.0M | −$176.1M | −30.78% |
| Q2 2012 | 2012-06-30 | $469.2M | −$65.3M | −12.22% |
| Q1 2012 | 2012-03-31 | $451.2M | −$72.9M | −13.91% |
| Q4 2011 | 2011-12-31 | $390.4M | −$68.0M | −14.83% |
| Q3 2011 | 2011-09-30 | $572.1M | $129.2M | +29.17% |
| Q2 2011 | 2011-06-30 | $534.5M | $19.4M | +3.77% |
| Q1 2011 | 2011-03-31 | $524.1M | $109.4M | +26.38% |
| Q4 2010 | 2010-12-31 | $458.4M | $55.9M | +13.89% |
| Q3 2010 | 2010-09-30 | $442.9M | $41.5M | +10.34% |
| Q2 2010 | 2010-06-30 | $515.1M | $116.3M | +29.16% |
| Q1 2010 | 2010-03-31 | $414.7M | $28.3M | +7.32% |
| Q4 2009 | 2009-12-31 | $402.5M | — | — |
| Q3 2009 | 2009-09-30 | $401.4M | −$19.3M | −4.59% |
| Q2 2009 | 2009-06-30 | $398.8M | $55.1M | +16.03% |
| Q1 2009 | 2009-03-31 | $386.4M | — | — |
| Q3 2008 | 2008-09-30 | $420.7M | — | — |
| Q2 2008 | 2008-06-30 | $343.7M | — | — |
Cme Group operating income trends
Over the last five fiscal years, Cme Group's operating income increased from $2.64B to $4.23B, a change of $1.59B. The latest reported quarter, Q2 2026, shows $1.11B.
What operating income means
Operating income is the profit or loss a company generates from its core business after cost of revenue and operating expenses, but before non-operating items such as interest and income taxes.
SEC-reported operating income
TickerStat standardizes operating income reported in company SEC filings for aligned fiscal periods. It is not adjusted EBIT, an analyst estimate, or company guidance. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Cme Group source filings ↗Community posts
CME plans European dairy futures and options through EEX transition
CME Group ($CME) agreed with the European Energy Exchange to transition EEX’s European dairy business, including its butter and skimmed-milk-powder indices, as EEX phases out those products. CME plans to establish its own European dairy ind ...
CME sets an FX open-interest record of 4.41 million contracts
CME Group reported a new foreign-exchange derivatives milestone on 7 September 2026. Reported records FX futures and options open interest reached 4,410,167 contracts on 4 September, exceeding the previous 4,269,622 record from 11 June. Tha ...